DOD Biotech PCL operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DOD Biotech PCL with three other
pharmaceutical manufacturers in Asia:
RPG Life Sciences Limited
sales of 3.76 billion Indian Rupees [US$51.19 million]
Mekophar Chemical Pharma JSC
(1.21 trillion Vietnamese Dong [US$52.78 million]
Caregen Co Ltd
based in KOREA (SOUTH)
(60.30 billion Korean Won [US$53.90 million]
of which 100%
was Cosmeceuticals&Dermal Filler).
During the first
quarter of 2021, sales at DOD Biotech PCL totalled
411.90 million Thai Bahts .
an increase of 20.6%
from the 341.60 million Thai Bahts in sales at the company during the first quarter of 2020.
During the previous 7 quarters, sales at DOD Biotech PCL have increased compared with the same quarter in the previous year.
DOD Biotech PCL reported sales of 1.61 billion Thai Bahts (US$51.72 million)
December of 2020.
increase of 104.0%
versus 2019, when the company's sales were 789.92 million Thai Bahts .
This was the fourth straight year of sales growth at DOD Biotech PCL.
Sales of Supplementary Business saw an increase
107.3% in 2020, from
551.18 million Thai Bahts to 1.14 billion Thai Bahts .